23rd Jun 2021 12:02
Braveheart Investment Group PLC - Barnsley-based investor in small- and medium-sized businesses - Provides update on Covid-19 test being developed by Paraytec Ltd, a wholly owned portfolio company. The test identified 94% of positive cases and 100% of negative cases, in clinical analyses of over 120 swab samples. It has the potential of being able to distinguish between infectious and non-infectious viral particles, which would be a "key advantage". Braveheart and Paraytec have started talks with potential commercial partners who have experience of Covid-19 testing.
Current stock price: 47.63 pence, up 11% on Wednesday
Year-to-date change: up 70%
By Ivan Edwards; [email protected]
Copyright 2021 Alliance News Limited. All Rights Reserved.
Related Shares:
Braveheart Investments